President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Americans spend more on prescription and over-the-counter drugs than anyone else in the world. It’s true that they take a lot ...

Lecanemab binds with high affinity to soluble amyloid-beta protofibrils. It won full FDA approval in July 2023 based on trial ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

Emphasizes that the United States aims to provide access to prescription drugs at lower costs for US patients and taxpayers, ...

While much of Washington, DC’s attention this week has been focused on congressional action around budget reconciliation, ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

RFK Jr., Trump, and Republicans want AI to fill the gaps as they move to throw millions off Medicaid, gut funding for ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

After significant fanfare and anticipation, President Trump issued his “Delivering Most-Favored Nation Prescription Drug Pricing to American ...

For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...